Browsing Tag
PTSD
3 posts
How the gammaCore PTSD study may influence bioelectronic medicine adoption in mental health
Can gammaCore’s PTSD study accelerate bioelectronic medicine adoption in mental health? Read what this means for electroCore, Inc. and the sector.
Biotech breakthrough in PTSD? Silo Pharma and Allucent move toward FDA IND filing for SPC-15 therapy
Silo Pharma partners with Allucent to advance its planned FDA IND for intranasal PTSD therapeutic SPC-15. Find out how this collaboration could shape future mental health treatment.
Is Emyria (ASX: EMD) stock ready to re-rate after Medibank funds its TRD program?
Emyria (ASX: EMD) secures Medibank backing for its TRD program, marking a milestone for insurer-funded mental health care. Can the stock sustain momentum?